Acne Medication Market Share

North America Market Forecast

North America in acne medication market is projected to hold more than 48.4% revenue share by 2037. The increasing prevalence of acne and advancements in drug formulation are prime factors boosting acne medication sales in North America. According to the American Academy of Dermatology, acne is the most common skin disorder among American people, affecting around 50 million individuals annually. Around 85% of people between ages 12 and 24 experience acne-related issues once in their lifetime.

The U.S. acne medication market is foreseen to increase at a CAGR of 5.5% from 2025 to 2037. Favourable government regulations and rising patient adoption of teledermatology promote market expansion. For instance, according to data published in the Journal of the American Academy of Dermatology, teledermatology consultations reached from 263 to 21,385 annually by 2020. Furthermore, guidelines for the use of telemedicine to provide patients with high-quality treatment during the pandemic were established by the Center for Disease Control and Prevention in 2020.

In Canada, acne is also one of the major skin issues affecting many individuals, hormonal changes and heredity are some of the prime reasons responsible for acne medication market growth. According to the Canadian Dermatology Association, 5.6 million individuals in the country are living with acne issues. Moreover, several companies in the country are actively launching innovative products that are fuelling the growth of the acne medication market. For instance, in December 2022, Bausch Health Companies Inc. announced the launch of ARAZLO a topical prescription medication for acne vulgaris treatment in Canada.

APAC Market Statistics

Asia Pacific market is expected to increase at a fast pace during the forecasted period owing to the rising awareness of skincare and related products and increasing consciousness about physical appearance among youngsters and adults. Additionally, rising disposable incomes and improved healthcare infrastructure in countries such as China, India, and Japan contribute to increased spending on acne treatments.

In China, the expanding middle class and increased disposable incomes, are rising investments in healthcare and skincare products, including acne medications. Additionally, the rise in e-commerce platforms and online pharmacies has made acne medications more accessible to a broader audience, particularly in urban areas.